Study Evaluating Betaferons Safety and Tolerability In Pediatric Patients With Multiple Sclerosis
Phase of Trial: Phase IV
Latest Information Update: 14 Jul 2017
At a glance
- Drugs Interferon beta-1b (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- Sponsors Bayer
- 07 Sep 2016 Status changed from active, no longer recruiting to completed.
- 22 Jul 2016 Planned End Date changed from 1 Jun 2016 to 1 Jul 2016.
- 21 Jun 2016 Planned End Date changed from 1 May 2016 to 1 Jun 2016.